A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610. [electronic resource]
Producer: 20190514Description: 379-382 p. digitalISSN:- 1465-3621
- Adult
- Bone Density Conservation Agents -- therapeutic use
- Bone Neoplasms -- drug therapy
- Bone and Bones -- pathology
- Curettage -- methods
- Denosumab -- therapeutic use
- Female
- Giant Cell Tumor of Bone -- drug therapy
- Humans
- Japan
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Osteotomy -- adverse effects
- Postoperative Complications -- prevention & control
- Research Design
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.